PMC:7405836 / 94632-95009
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T332 | 25-29 | Body_part | denotes | mRNA | http://purl.org/sig/ont/fma/fma67122 |
| T333 | 64-67 | Body_part | denotes | DNA | http://purl.org/sig/ont/fma/fma74412 |
| T334 | 220-223 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T876 | 35-43 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T877 | 35-39 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T878 | 137-140 | Disease | denotes | Ad5 | http://purl.obolibrary.org/obo/MONDO_0011194 |
| T879 | 250-258 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T880 | 288-296 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T881 | 325-333 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T866 | 152-153 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T867 | 317-324 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptide |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T27594 | 64-67 | Chemical | denotes | DNA | http://purl.obolibrary.org/obo/CHEBI_16991 |
| T98108 | 317-324 | Chemical | denotes | peptide | http://purl.obolibrary.org/obo/CHEBI_16670 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T658 | 0-377 | Sentence | denotes | Vaccine candidates, like mRNA-1273 SARS-CoV-2 vaccine, INO-4800 DNA coronavirus vaccine, and adenovirus type 5 vector vaccine candidate (Ad5-nCoV), are a few examples under phase I clinical trials, while self-amplifying RNA vaccine, oral recombinant COVID-19 vaccine, BNT162, plant-based COVID-19 vaccine, and Ii-Key peptide COVID-19 vaccine are under preclinical trials (297). |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2578 | 35-45 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 2579 | 68-79 | Species | denotes | coronavirus | Tax:11118 |
| 2580 | 93-110 | Species | denotes | adenovirus type 5 | Tax:28285 |
| 2581 | 141-145 | Species | denotes | nCoV | Tax:2697049 |
| 2586 | 250-258 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 2587 | 288-296 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 2588 | 325-333 | Disease | denotes | COVID-19 | MESH:C000657245 |